cms glp-1 Issues Coverage Guidance on Anti-Obesity Drugs CMS Update on BALANCE Model

Digestive health symptoms are the #1 barrier to GLP-1 adherence

Strengthen, rebalance, and regrow your hair with this potent, nutrient-rich organic duo

Specifically, GLP-1 RAs showed significantly reduced risks of progression to systolic heart failure (HR 0.60) and stroke (HR 0.75) compared to SGLT2 inhibitors

When varying the grace period between 60 days and 365 days, treatment discontinuation rates at 3 years ranged from 23.3% to 43.6% among GLP-1 receptor agonist users and from 28.8% to 50.6% among SGLT2 inhibitor users

In this article, learn that and more including what insulin is, how to spot the signs of insulin resistance, and what the health effects of high blood sugar can be.